Vito M Campese Selected Research

Vito M Campese Research Topics

Disease

20	Hypertension (High Blood Pressure) 01/2014 - 02/2002
9	Chronic Renal Insufficiency 10/2014 - 03/2003
8	Kidney Diseases (Kidney Disease) 04/2014 - 03/2003
7	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 06/2002
6	Proteinuria 02/2012 - 03/2003
5	Dyslipidemias (Dyslipidemia) 04/2014 - 01/2005
4	Inflammation (Inflammations) 10/2014 - 01/2005
3	Fibrosis (Cirrhosis) 08/2010 - 05/2009
2	COVID-19 05/2021 - 01/2021
2	Dehydration (Water Stress) 02/2021 - 01/2017
2	Coronary Disease (Coronary Heart Disease) 10/2014 - 01/2013
2	Overweight 12/2012 - 04/2006
2	Glomerulonephritis 02/2012 - 04/2010
2	Hyperkalemia 04/2010 - 12/2009
2	Insulin Resistance 01/2010 - 04/2006
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2021
1	Hyperuricemia 02/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2021
1	Infections 02/2021
1	Hypotension (Low Blood Pressure) 01/2017
1	Chronic Kidney Diseases of Uncertain Etiology 01/2017
1	Transient Ischemic Attack 10/2014
1	Diabetes Mellitus 10/2014
1	Stroke (Strokes) 10/2014
1	Acute Kidney Injury (Acute Renal Failure) 04/2014
1	Type 2 Diabetes Mellitus (MODY) 12/2013
1	Hematuria 02/2012
1	IGA Glomerulonephritis (IGA Nephropathy) 02/2012
1	Pyoderma Gangrenosum 02/2012
1	Ulcerative Colitis 02/2012
1	Graves Disease (Basedow Disease) 02/2012
1	Drug-Related Side Effects and Adverse Reactions 07/2010
1	Hyponatremia 05/2009
1	Heart Failure 05/2009
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2009
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 05/2009
1	Inappropriate ADH Syndrome (SIADH) 05/2009
1	Ascites 05/2009
1	Myocardial Infarction 05/2008
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 05/2008
1	Pathologic Constriction (Stenosis) 05/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2008
1	Angina Pectoris 05/2008
1	Renal Hypertension 11/2006
1	Essential Hypertension 04/2006

Drug/Important Bio-Agent (IBA)

9	Phenol (Carbolic Acid)FDA Link 01/2009 - 02/2002
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2014 - 03/2003
6	AldosteroneIBA 08/2010 - 07/2005
5	SodiumIBA 01/2014 - 07/2002
4	SaltsIBA 01/2014 - 06/2002
4	Angiotensin IIIBA 12/2009 - 09/2003
3	LipidsIBA 04/2014 - 03/2003
3	DiureticsIBA 01/2014 - 08/2007
3	Antihypertensive Agents (Antihypertensives)IBA 12/2013 - 06/2002
3	Proteins (Proteins, Gene)FDA Link 04/2010 - 11/2004
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2003 - 06/2002
2	Atorvastatin (Lipitor)FDA Link 10/2014 - 03/2003
2	LDL CholesterolIBA 10/2014 - 04/2006
2	CholesterolIBA 10/2014 - 01/2013
2	Pharmaceutical PreparationsIBA 01/2014 - 07/2010
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2012 - 10/2008
2	Coenzyme A (CoA)IBA 09/2011 - 03/2003
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 08/2010 - 12/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2009 - 08/2004
2	Insulin (Novolin)FDA Link 05/2008 - 04/2006
2	CytokinesIBA 10/2005 - 03/2005
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2005 - 03/2003
2	Protein Isoforms (Isoforms)IBA 05/2003 - 02/2002
2	Nitric Oxide Synthase (NO Synthase)IBA 07/2002 - 02/2002
2	Losartan (Cozaar)FDA LinkGeneric 06/2002 - 02/2002
1	GlucocorticoidsIBA 05/2021
1	Heavy MetalsIBA 02/2021
1	Immunoglobulin A (IgA)IBA 02/2012
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2012
1	Peroxidase (Myeloperoxidase)IBA 02/2012
1	Mineralocorticoid Receptor AntagonistsIBA 08/2010
1	CreatinineIBA 04/2010
1	Angiotensin Receptor AntagonistsIBA 01/2010
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2010
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2010
1	Telmisartan (Micardis)FDA Link 01/2010
1	ReninIBA 12/2009
1	AngiotensinsIBA 12/2009
1	lixivaptanIBA 05/2009
1	Vasopressins (Vasopressin)IBA 05/2009
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2009
1	Superoxide DismutaseIBA 01/2009
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2009
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 08/2007
1	AntioxidantsIBA 07/2007
1	Vitamin E FDA LinkGeneric 07/2007
1	Ouabain (G Strophanthin)IBA 11/2006
1	Glucose (Dextrose)FDA LinkGeneric 04/2006
1	AlbuminsIBA 04/2006

Therapy/Procedure

6	Therapeutics 01/2021 - 07/2005
2	Renal Dialysis (Hemodialysis) 01/2017 - 01/2010
2	Denervation 01/2014 - 12/2013
2	Nephrectomy 06/2002 - 02/2002
1	Fluid Therapy (Oral Rehydration Therapy) 01/2017
1	Peritoneal Dialysis 01/2010